Please login to the form below

Not currently logged in
Email:
Password:

New VP for Merz North America

Gregory Bass to lead market access and reimbursement strategy
Merz Gregory Bass

Healthcare company Merz Pharma has appointed Gregory Bass vice president, managed markets .

Bass will be responsible for developing Merz's North American market access and reimbursement strategy to enhance patient access to Merz prescription products.

Joining Merz's North America leadership team and reporting directly to Bill Humphries, president and CEO of Merz North America, Bass will be based in Greensboro, North Carolina, at the company's North American headquarters.

An industry veteran, Bass has spent 17 years in the pharma and biopharmaceutical sectors, and joins Merz from Johnson & Johnson Healthcare Systems, where he was senior director, managed markets.

"Greg brings broad experience in the industry across multiple specialities, including oncology, immunology, dermatology and neurology," said Bill Humphries.

“His success in previous sales, marketing and managed market roles, along with his reputation for driving team performance and strategic results makes him an ideal fit for a growing and customer-focused company like Merz."

6th March 2014

From: Sales, Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics